TrialCancer2026

Vobramitamab duocarmazine, an anti-B7-H3 antibody-drug conjugate, in patients with advanced solid tumors: Final results of a phase 1 cohort expansion.

Eugene Shenderov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.